Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Saint Herblain (France), April 26, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that France's national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation for use of Valneva's single-dose chikungunya vaccine IXCHIQ® for the prevention of disease caused by the chikungunya virus (CHIKV) following reports of serious adverse events (SAEs) in elderly people with comorbidi…

The health authorities were informed of three "serious adverse events", including one death, that occurred in more than 80 years of age with co-morbidities.

After three "serious adverse events" including one death in Réunion, the health authorities decided this Friday 25 April to withdraw "without delay" the more than 65 years from the vaccination campaign against the chikungunya epidemic for the island of the Indian Ocean and Mayotte. The 100,000 doses of vaccine purchased so far were intended as a priority... for seniors with co-morbidities.

"Vaccination remains open for people between the ages of 18 and 64 with co-morbidities," said the Ministry of Health in a statement.

In the face of three serious incidents, including one death, the health authorities suspended the over 65-year-old vaccination against chikungunya in La Réunion and Mayotte. Friday 25 April 2025, the management of the epidemic and...

Paris, 26 Apr 2025 (AFP) – The fight against the chikungunya epidemic in La Réunion is complicated: the health authorities have recently withdrawn "without delay" the more than 65 years of the vaccination campaign for the island of the Indian Ocean and Mayotte after three "serious adverse events" including one death. This decision comes a few weeks [...]